Printer Friendly

SANDOZ GROUP REPORTS RESULTS FOR 1991

 SANDOZ GROUP REPORTS RESULTS FOR 1991
 BASLE, Switzerland, Jan. 23 /PRNewswire/ -- The Sandoz Group


(ADR-OTC: SDOZY) achieved consolidated sales of Sfr13.4 billion in 1991, an increase of more than Sfr1 billion, corresponding to a 9 percent growth in Swiss Francs over the previous year. In local currencies, excluding the exchange rate impact in high-inflation countries, group sales grew 7 percent.
 For the individual businesses, sales were as follows:
 Growth:
 in local
 1991 1990 in Sfr currencies
 Sfr billion Sfr billion percent Percent (A)
 Chemicals 2.35 2.28 3 3
 Pharma 6.37 5.68 12 10
 Argo 1.16 1.15 1 2
 Seeds 0.95 0.92 3 6
 Nutrition 1.54 1.34 15 14
 Construction &
 Environment 1.07 1.00 7 2
 Total 13.44 12.37 9 7
 (A) Exchange-rate impact in high-inflation countries excluded
 Growth in the Sandoz Group in 1991 was led by strong sales increases in Pharma and Nutrition. Despite a slow-down in the world economy, the other group companies also progressed.
 In Chemicals, sales accelerated in the second half of the year to yield a satisfactory performance in comparison to the rest of the industry. Business was particularly active in Asia.
 Through organic growth, Pharma gained ground in the major markets, notably the United States and Europe. The increment was led by sales increases of more than 13 percent in the prescription drug business, with the No. 1 product Sandimmun, Leponex/Clozaril, Sandostatin and Lomir/DynaCirc as key contributors.
 In a market characterized by unfavorable weather conditions, Argo sales improved only slightly over the previous year.
 Seeds achieved good progress in European vegetable and flower seeds markets and also increased sales in field crops, particularly sugar beets.
 The Wander and Wasa product lines contributed to strong growth for Nutrition. This increase was further stimulated by sales by the Eden Group and Dietetique et Sante, two recent acquisitions which helped the company achieve a leading position in adult dietetics in France, Germany, and Spain.
 For Construction & Environment, activities were characterized by a slackening in the construction sector and favorable development of the Environment business. The contraction and demand in construction was particularly felt in North America and Europe. In the Far East, the progress of our activities was continued.
 Thanks for the efficiency and flexibility of our organization, the operating margin was preserved in a difficult economic climate. The healthy growth of the company's business, and a favorable impact of exchange rates, are expected to result in a satisfactory increase in consolidated earnings.
 -0- 1/23/92
 /CONTACT: Craig Burrell, M.D. (media), 201-503-8230; or James R. Simpson (investors), 212-830-2444, both of Sandoz/
 (SDOZY) CO: Sandoz Group ST: New Jersey IN: MTC SU: ERN


JT-SH -- NY046 -- 2794 01/23/92 12:11 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 23, 1992
Words:462
Previous Article:MARYLAND SECRETARY OF AGRICULTURE ATTENDS CONFERENCE ON AID TO FORMER SOVIET REPUBLICS
Next Article:MORTON INTERNATIONAL DECLARES QUARTERLY DIVIDEND
Topics:


Related Articles
SANDOZ ANNOUNCES JUNE SALES RESULTS
AFFYMAX REPORTS SECOND QUARTER RESULTS
SANDOZ GROUP REPORTS RESULTS FOR 1992
SANDOZ LTD. ANNOUNCES EARNINGS
SANDOZ HIGHLIGHTS ITS 1993 RESULTS AND ANNOUNCES 1994 FIRST QUARTER SALES
SANDOZ IMPROVES OPERATING INCOME BY 7%
SANDOZ SIGNS DEBT ISSUANCE PROGRAM
SANDOZ ANNOUNCES FIRST HALF SALES UP 17% IN LOCAL CURRENCIES, 6% IN SWISS FRANCS
SANDOZ ANNOUNCES 16% GROWTH IN LOCAL CURRENCIES FOR SALES TO SEPTEMBER 30
SANDOZ ANNOUNCES 14% GROWTH IN LOCAL CURRENCIES FOR SALES IN 1995

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters